BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Insight

Cell & Gene Therapy in Asia Pacific: Revolutionizing Disease Treatment

Cell and gene therapies are revolutionizing the way we think about treating diseases. These advanced therapies have the potential to cure a range of illnes...

February 27, 2023 | Opinion

Precision Medicine Takes Center Stage: Exploring the Innovative Biopharma Industry in Australia and New Zealand

Australia and New Zealand have always been at the forefront of innovation and research in the biopharma industry. The region's strategic location and stron...

February 24, 2023 | News

Biosimilars Revolutionizing Healthcare in Asia Pacific: A Promising Future Ahead

These products are biologic drugs that are highly similar to an already approved reference biologic drug and are designed to provide cost-effective alterna...

February 23, 2023 | News

Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV

Presentation at Conference on Retroviruses and Opportunistic Infections (CROI) demonstrates association between excess visceral abdominal fat (EVAF) redu...

February 23, 2023 | News

"Fueling Growth and Innovation: The Rise of Biotech Investment in the Asia Pacific Region"

According to a report by Deloitte, the APAC biotech market is expected to grow at a compound annual growth rate (CAGR) of 10.9% between 2020 and 2025, with...

February 20, 2023 | News

Biomimicry in Biotech: Researchers Look to Nature for Solutions to Human Health Problems

By studying and replicating natural systems, scientists are uncovering new avenues for drug development, medical device design, and even disease prevention...

February 17, 2023 | Opinion

Merck announced findings of a new analysis of long-term follow-up data from the Phase III JAVELIN Bladder 100 trial

Long-term follow-up of the Phase III JAVELIN Bladder 100 study demonstrated median overall survival from start of chemotherapy of 29.7 months among patie...

February 16, 2023 | News

BeiGene Aim to Accelerate Integration of Mental Health into Quality Cancer Care

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, has released a report highlighting the challenges cancer patients and car...

February 03, 2023 | News

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcom...

February 01, 2023 | News

4 Medical Device Quality Trends for 2023

New guidance documents from regulators, a new approach to inspections, and cybersecurity risks all pose a challenge. The good news is th...

January 21, 2023 | News

6 Must-Haves for a Quality Management System

Choose the best one for your business by learning about the 6 essentials that an eQMS needs to be effective. If an eQMS doesn't check the...

January 18, 2023 | News

Pharma Industry Trend Brief: 2023 Manufacturing Trends

Worried about what the future holds for the pharmaceutical industry? This trend brief examines how manufacturers can take advantage of mo...

January 18, 2023 | News

23 LifeScience Companies Changing the World : BioPharma APAC 2023 Outlook

These companies are often involved in the research, development, and production of pharmaceuticals, medical devices, and other health-related products.&nbs...

January 03, 2023 | News

The Best of 2022: FDA Approvals and the Breakthroughs That Enabled Them

For a field like cancer research, in which progress can sometimes appear to happen slowly, it is especially important to remind ourselves of the crucial ad...

December 31, 2022 | News | By Calley Jones, PhD

Stay Connected